MASI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Masimo Corp

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Masimo's mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.4 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,5 improve CCHD screening in newborns,6 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.7-10 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,11 and is the primary pulse oximetry at 9 of the top 10 hospitals according to the 2020-21 U.S. News and World Report Best Hospitals Honor Roll.12 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient's physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo's family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView :60™, and Masimo SafetyNet™.
CEO
Joe Kiani
Employees
2000
Headquarters

52 Discovery
Irvine, California 92618-3105
Phone: 19492977000
www.masimo.com

News

Securities fraud class action lawsuits target UiPath, Shift4 Payments, Masimo Corporation, and Enviva
Oct 03, 2023 06:04am

https://www.investing.com/news/stock-market-news/securities-fraud-class-action-lawsuits-target-uipath-shift4-payments-masimo-corporation-and-enviva-93CH-3188683


Source:Investing.com
MASI CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Masimo Corporation (MASI) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending
Oct 02, 2023 13:58pm

SAN FRANCISCO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Masimo Corporation (NASDAQ: MASI) investors who suffered substantial losses to submit your losses now .


Source:GlobeNewswire
Masimo Shareholder Alert
Oct 01, 2023 22:14pm

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Masimo To Contact Him Directly To Discuss Their Options When you purchased or acquired securities in Masimo stock or options between February 28, 2023 and July 17, 2023 and would love to debate your legal rights, call Faruqi & Faruqi partner Josh Wilson […] The post Masimo Shareholder Alert appeared first on TodaysStocks.com .


Source:TodaysStocks.com
MASI INVESTOR NEWS: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Masimo Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MASI
Sep 30, 2023 03:16am

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Masimo Corporation (NASDAQ: MASI) between February 28, 2023 and July 17, 2023, both dates inclusive (the “Class Period”), of the important October 23, 2023 lead plaintiff deadline .


Source:GlobeNewswire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Masimo Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - MASI
Sep 28, 2023 00:30am

NEW YORK, Sept. 27, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Masimo Corporation (NASDAQ: MASI) between February 28, 2023 and July 17, 2023, both dates inclusive (the "Class Period"), of the important October 23, 2023…


Source:PR Newswire
Unveiling Masimo (MASI)''s Value: Is It Really Priced Right? A Comprehensive Guide
Sep 27, 2023 23:38pm

Unveiling Masimo (MASI)''s Value: Is It Really Priced Right? A Comprehensive Guide


Source:GuruFocus
MASIMO CORPORATION (NASDAQ: MASI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Motion Lawsuit Against Masimo Corporation
Sep 27, 2023 13:44pm

NEW YORK, NY / ACCESSWIRE / September 27, 2023 / Bernstein Liebhard LLP: Do you, or did you, own shares of Masimo Corporation (NASDAQ:MASI)? Did you buy your shares between February 28, 2023 and July 17, 2023, inclusive? Did you lose money in your investment in Masimo Corporation? Do you desire to discuss your rights? […] The post MASIMO CORPORATION (NASDAQ: MASI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Motion Lawsuit Against Masimo Corporation appeared first on TodaysStocks.com .


Source:TodaysStocks.com
Masimo: Lots Of Questions
Sep 25, 2023 21:54pm

Masimo Corporation shares fell after announcing a ''diworsification'' move for Sound United. Read more to see a detailed analysis on MASI stock.


Source:Seeking Alpha
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Masimo Corporation Investors to Secure Counsel Before Essential Deadline in Securities Class Motion – MASI
Sep 23, 2023 23:32pm

(NewMediaWire) WHY: NEW YORK, NY – (NewMediaWire) – September 23, 2023 – Rosen Law Firm, a worldwide investor rights law firm, reminds purchasers of securities of Masimo Corporation (NASDAQ: MASI) between February 28, 2023 and July 17, 2023, each dates inclusive (the “Class Period”), of the essential October 23, 2023 lead plaintiff deadline. SO WHAT: […] The post ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Masimo Corporation Investors to Secure Counsel Before Essential Deadline in Securities Class Motion – MASI appeared first on TodaysStocks.com .


Source:TodaysStocks.com
MASIMO DEADLINE REMINDER : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Masimo To Contact Him Directly To Discuss Their Options
Sep 22, 2023 01:08am


Source:Kwhen Finance